Discussing Quality-of-Life Issues with a Patient Newly Diagnosed with Prostate Cancer
Published in: Nature Clinical Practice Urology, v. 3, no. 8, Aug, 2006, p. 449-452
Posted on RAND.org on January 01, 2006
BACKGROUND: A 66-year-old man with hypertension, hyperlipidemia, and benign prostatic hyperplasia presented for evaluation of an elevated PSA level of 6.2 ng/ml. INVESTIGATIONS: Transrectal ultrasound-guided 12-core prostate needle biopsy. DIAGNOSIS: Clinically localized, clinical stage T1c adenocarcinoma of the prostate. MANAGEMENT: Following a full discussion of the risks and benefits of his treatment options, including quality-of-life sequelae, the patient opted for radical prostatectomy.
This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.